Large-Scale Homoeoprophylaxis Interventions by government institutions

Posted on 10 March 2023 by Dr Isaac Golden PhD

Deputy Chair and Research Consultant, Ethics, Consultant, National Institute of Integrative Medicien, Melbourne, Australia

Keywords: homoeoprophylaxis, infectious diseases, transitory, established, immunization, government sponsorship, genus 
epidemicus, nosodes, Cuba, India, Brazil, Leptospirosis, Hepatitis A, Swine flu, Pneumonia, Dengue, Japeneese Encephalitis, Meningitis

Published in Similia, The Australian Journal of Homoeopathic Medicine. Volume 31, Number 2. Hobert, Tasmania. December 2019. 

Abstract

Introduction: The term homoeoprophylaxis (HP) was first coined by Burnett in 1884 to refer to medicines selected according to the Law/Principle of Similars to prevent targeted infectious diseases. HP medicines were first used by Hahnemann in 1798 and have been used since to protect significant numbers of people against a range of infectious diseases in many countries. This paper updates a recent analysis of HP use internationally, and examines a large intervention conducted over 11 years.

Read more here